Time to dry analysis of brolucizumab vs aflibercept in patients with neovascular AMD: 96-week data from the HAWK and HARRIER trials

Ian McAllister, Eric Souied, Carl Regillo, David Brown, Frank Holz, David Tanzer, Jahangir Alam, Pravin Dugel

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)149-150
Number of pages2
JournalClinical and Experimental Ophthalmology
Publication statusPublished - Nov 2019

Cite this